SEC Filings TLDR

Sandi Mae V. See Tai, an officer of Lexeo Therapeutics, Inc., reported the sale of 3,888 common shares on October 17, 2025, with an aggregate market value of $34,766.88. The shares were acquired on October 15, 2025, through the vesting of restricted stock as part of compensation. Additionally, See Tai sold 382 common s...

Asia Equity Partners Ltd. has filed a Form 144 with the SEC, indicating its intention to sell 1,190,456 American Depositary Shares (ADSs) of Joint Stock Company Kaspi.kz. The shares were acquired through a private placement on November 22, 2006. The filing also details extensive sales activity over the past three month...

On October 17, 2025, John Strosahl, an officer of Jamf Holding Corp., filed a Form 144 with the SEC regarding the vesting of restricted stock. The filing indicates that 43,650 shares of common stock vested on October 15, 2025, under a registered plan. The aggregate market value of these shares was approximately $431,11...

John C. Reed, an officer at Johnson & Johnson, has filed a Form 144 indicating the sale of 21,721 common shares on October 17, 2025, with an aggregate market value of $4,185,794.26. These shares were acquired through an option granted on February 15, 2024. Additionally, Reed sold 19,137 common shares on July 17, 2025, ...

Mark Mondello, a director of Jabil Inc, has filed a Form 144 notice indicating the sale of 40,000 common shares of Jabil Inc. The shares were acquired on October 24, 2023, and the notice was signed on October 17, 2025. The aggregate market value of the shares to be sold is approximately $8,317,915. Additionally, Mondel...

Robert I. Kauffman, a director of Hagerty Inc., has reported significant sales of the company's common stock over the past three months. The sales, conducted through Aldel LLC, totaled over $7 million, with individual transactions ranging from $31,589 to $1,156,876. The largest single sale occurred on July 24, 2025, in...

Michael M Achary, an officer of Hancock Whitney Corp, has filed a notice of intent to sell 9,894 shares of common stock on October 17, 2025. The shares were acquired through equity compensation on various dates in 2023. The aggregate market value of the shares to be sold is $542,537.49. The sale will be conducted throu...

John M. Hairston, an officer of Hancock Whitney Corp, has filed a Form 144 notice indicating his intention to sell 21,883 shares of the company's common stock. The shares were acquired through stock grants on various dates, including November 1, 2022, January 26, 2023, and February 1, 2023. The aggregate market value o...

Tariq Musa, a director at Guardant Health, Inc., has filed a Form 144 notice indicating the intent to sell 116 shares of common stock acquired through a restricted stock lapse. The shares were acquired on October 15, 2025, and the notice was filed on October 17, 2025. The plan for these securities was adopted on Septem...

Myrtle S Potter, a director at Guardant Health, Inc., has filed a Form 144 with the SEC. The filing details the planned sale of 26 shares of common stock, acquired through a restricted stock lapse on October 15, 2025. The shares are to be sold on October 17, 2025, with an aggregate market value of $1,741. The filing al...

Brian Robins, an officer at GitLab Inc., exercised stock options for 134,679 shares of common stock on October 17, 2025. The aggregate market value of these shares was approximately $6,300,674.19. Additionally, Robins sold 19,177 shares of common stock on September 16, 2025, with gross proceeds of $955,012.68. The tran...

Enric Alventosa Abril, an officer of Freightos Ltd, has reported securities transactions involving the sale of Ordinary shares. The filing details the sale of 2,177 shares on October 16, 2025, with an aggregate market value of $7,946.05. Additionally, the filing reports past transactions, including the sale of 5,005 sh...

Windsor Private Capital LP, a 10% stockholder of Firefly Neuroscience, Inc., has reported multiple sales of the company's common stock over the past three months. The sales occurred between October 9, 2025, and October 16, 2025, with total gross proceeds exceeding $611,000. The securities were acquired on August 12, 20...

Benjamin Looker, an officer at Esperion Therapeutics, Inc., has reported securities transactions involving the company's common stock. On October 15, 2025, Looker acquired 1,248 shares through restricted stock vesting as part of compensation. These shares are set to be sold on October 17, 2025, with an aggregate market...

Samuel Kintz, an officer of Enliven Therapeutics, Inc., has filed a notice of intent to sell 12,500 common shares of the company. The shares, acquired as founder shares on September 1, 2019, are to be sold pursuant to a 10b5-1 selling plan adopted on November 15, 2024. The sale is scheduled for October 17, 2025, with a...

The filing details the securities transactions of Stanton Dodge, an officer of DraftKings Inc., involving the company's Class A Common stock. The transactions include the vesting of restricted stock units and the exercise of stock options. Specifically, Dodge acquired 454 shares on October 1, 2025, through the vesting ...

Atlas Venture Fund X, LP has filed a notice of sale of 50,000 shares of common stock in Disc Medicine, Inc. The shares were acquired on May 1, 2020, through a private placement. The notice, signed by Ommer Chohan on October 17, 2025, indicates that the shares are to be sold on the same date. The aggregate market value ...

Atlas Venture Opportunity Fund II, L.P. has filed a notice with the SEC regarding the sale of securities in Disc Medicine, Inc. The filing details the sale of 35,000 common shares acquired through a private placement on December 17, 2022. The notice, signed by Ommer Chohan on October 17, 2025, also includes information...

Atlas Venture Opportunity Fund I, L.P. has filed a notice of sale of 35,000 common shares of Disc Medicine, Inc. on October 17, 2025. The shares were acquired through a private placement on October 7, 2020. The aggregate market value of the shares to be sold is approximately $3,147,900. Additionally, the filing details...

Stephen T. O'Rourke, Director and Co-Chairman of Dakota Gold Corp., has sold 50,000 shares of the company's common stock. The shares were sold on October 16, 2025, for a total value of $266,835. The securities were originally acquired on June 4, 2021, through the vesting of Restricted Stock Units (RSUs). The sale was e...

Robert Aflatooni, an officer at Dollar Tree, Inc., has filed a Form 144 with the SEC indicating the intent to sell 1,260 shares of common stock. The shares were acquired on August 26, 2025, through a restricted stock lapse as part of equity compensation. The approximate sale date is set for October 17, 2025, with an ag...

The Meryl S Paul 2023 Trust has filed a Form 144 with the SEC, indicating its intention to sell 40,000 common shares of Credit Acceptance Corp. The shares were acquired on September 11, 2011, through a GRAT Remainder transaction. The proposed sale is part of a pre-paid variable share forward contract with an affiliate ...

The SEC filing details the planned sale of securities by Jamie Reynoso, an officer of Clover Health Investments, Corp. The filing, submitted on October 17, 2025, outlines the sale of 16,514 common stock units acquired as Restricted Stock Units on October 15, 2025. The plan for these sales was adopted on March 13, 2025....

Wan Shan Chen, an affiliate of Belite Bio, Inc, has filed a notice of securities sale under Rule 144. The filing details the sale of 9,550 common shares of Belite Bio, Inc, with an aggregate market value of $1,164,500. The securities were acquired through non-qualified stock awards on December 29, 2020, and August 26, ...

Fred Aslan, a director and officer of Artiva Biotherapeutics, Inc., has filed a Form 144 to notify the SEC of his intention to sell 25,500 shares of the company's common stock. The shares were acquired on August 15, 2025, as Restricted Stock Units. The sale is planned to occur on or around October 17, 2025, with an agg...